Polish firm will be able to produce the vaccine, deal with Novavax

 Thanks to the Polish Development Fund's financial support, the Polish pharmaceutical company, Mabion, will produce a vaccine against Covid-19 developed by the American company Novavax. The necessary test production will start in this quarter.

The Polish government has carefully planned the logistics of the National COVID-19 Immunization Program. Its effectiveness is demonstrated by over 3,000,000 doses that have already been administered to Poles. We are one of the fastest vaccinating countries in Europe, and the only factor that limits us is the still insufficient number of vaccines from their producers - wrote PM Morawiecki.